LILRB3 suppresses immunity in glioma and is associated with poor prognosis
Open Access
- 13 October 2023
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 13 (10) , e1396
Abstract
No abstract availableFunding Information
- National Key Research and Development Program of China (2020YFA0804200)
- Science and Technology Commission of Shanghai Municipality (20Z11900100)
- National Natural Science Foundation of China (82073166, 82273203)
This publication has 10 references indexed in Scilit:
- Lipid-accumulated reactive astrocytes promote disease progression in epilepsyNature Neuroscience, 2023
- Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastomaCancer Cell, 2022
- LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2–cFLIP–NF-κB signaling axisNature Cancer, 2021
- Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastomaCancer Cell, 2021
- Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specializationNature Neuroscience, 2021
- TGFβ biology in cancer progression and immunotherapyNature Reviews Clinical Oncology, 2020
- An Integrative Model of Cellular States, Plasticity, and Genetics for GlioblastomaCell, 2019
- Defining and Understanding Adaptive Resistance in Cancer ImmunotherapyTrends in Immunology, 2018
- Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human GlioblastomaCell Reports, 2017
- Effects of exogenous apo E-3 and of cholesterol-enriched meals on the cellular metabolism of human chylomicrons and their remnantsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991